The matter of review of experimental protocols is dealt with in the section of the Declaration headed Basic Principles where it says under Point 2: 'The design and performance of each experimental procedure involving human subjects should be clearly formulated in an experimental protocol which should be transmitted to a specially appointed independant committee for consideration, comment and guidance.' There is an equally concise comment on the matter of consent under Point 9. 'In any research on human beings, each potential subject must be adequately informed of the aims, methods, anticipated benefits and potential hazards of the study and the discomfort it may entail. He or she should be informed that he or she is at liberty to abstain from participation at any time. The Doctor should then obtain the subject's freely-given informed consent, preferably in writing. ' One would expect in 1988 that the excuse for failure to submit a protocol to a committee for review which has been heard in the past, namely that at the time of inception of the project the institution did not have one, would no longer apply. Clearly, the time for equivocation on these matters is over. The principles involved have been acknowledged as corrrect by the profession for over twenty years. No dramatic change in behaviour is sought from those engaged in research, just compliance with standards long acknowledged by our peers as reasonable. It is expected that in future, manuscripts will contain a statement specifying that the study was approved by an ethics committee prior to its commencement and that the subjects gave informed consent to participate.
The requirement for all protocols to be favourably reviewed by a committee prior to their commencement does oblige those who serve on such ethics and research committees to deal promptly with uncomplicated protocols submitted for their consideration. They must not put obstructions in the path of the investigator for trivial or pedantic reasons. That path is tough enough without that.
Those embarking on their first investigations may be inclined to view these two requirements as disincentives to proceed. Discussions with more experienced researchers will convince them otherwise. Just as every aspect of clinical practice is today coming under ever-closer scrutiny by the press, the law, the Government, and the public, so it is with all medical research. Compliance with these requirements should afford the individual investigator protection against any mischievious allegations of impropriety from whatever quarter. Furthermore, it should reassure the public that our research projects are reasonable, our motives worthy and our techniques sound.
Having dealt with the matter of studies involving human subjects, the Editorial Committee discussed research involving animals. For reasons similar to those in the discussions above, the following insertion was made to the Guide to Authors; '... those (studies) using animals must comply with National Health and Medical Research Council Guidelines or their equivalent.' The Code of Practice for the Care and Use of Animals for Experimental Purposes (I 985) is readily available from the Publications Section of the National Health and Medical Research Council (P.O. Box 100, Woden, A.C.T. 2606, Australia).
Finally, it was determined that papers when submitted should be accompanied by a letter signed by all the authors indicating that the paper has not been published previously and is not currently undergoing assessment for publication elsewhere and also that each author contributed substantially to the paper.
